Jaime is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an assistant editor.
She has a BA in print journalism from Penn State University. You can connect with Jaime on LinkedIn.
Levels of Certain Thyroid Hormone May Help With Risk Stratification in MMMay 4th 2022
With survival of multiple myeloma ranging from less than 1 month to over 10 years, the researchers highlighted the importance of risk stratification to quickly identify patients who are high risk with poor prognosis and could benefit from different treatment strategies and close surveillance.
Poorer Outcomes Associated With Recurrent aGVHD Warrant Independent Recognition, Says StudyMay 2nd 2022
After a median follow-up of 535 days, analysis showed that recurrent acute graft-versus-host disease (RaGVHD) carried several implications for survival, leading the researchers to call for further risk stratification of aGVHD.
Study Gives Insight Into Fidaxomicin’s Gut-Sparing Activity in Clostridioides difficileMay 2nd 2022
Fidaxomicin, now commonly used to treat Clostridioides difficile infection, selectively targets the bacterium while sparing crucial gut commensals that protect against colonization. However, knowledge gaps in the molecular basis of its narrow-spectrum activity remain.
Study Finds Risk of Overinvestigation in Patients With Lung Cancer Not Fit for Anticancer TreatmentApril 30th 2022
Among a group of patients with lung cancer who were not suitable for anticancer treatment, the researchers found that 40% underwent additional investigations after their initial CT scan before eventually receiving best supportive care.
Study: Effective Treatment Significantly Improves HRQoL in Recurrent Clostridioides difficileApril 30th 2022
The researchers wrote that their findings showcase the need for close monitoring of patients and for effective treatments for those with recurrent infection, which occurs in 15%-30% of all patients with Clostridioides difficile.
MoCA Scores in HD Correlate With Caudate Atrophy, Cortical Thinning, Says New ResearchApril 24th 2022
The findings suggest that the tool can be used to not only assess cognitive impairment in Huntington disease (HD) but also to detect brain atrophy patterns associated with cognitive status in these patients.
New Study Details Frequency of SDOH Documentation Among Patients With Lung CancerApril 22nd 2022
A decade’s worth of data included more than 5 million social determinants of health (SDOH) attributes across nearly 2 million clinical notes from the patient visits extrapolated from a natural language processing system.
Pretreatment PROs May Have Survival Implications in DLBCL, Finds Exploratory StudyApril 12th 2022
The researchers found that the prognostic values for both overall and progression-free survival remained even after adjusting for the International Prognostic Index, a widely used prognostic model of outcomes for the disease.
European Study Shows High Rate of Skin Conditions, DiseasesApril 8th 2022
When including patients who had a mole check or cancer screening, the proportion of patients with at least 1 dermatological condition or disease increased to 47%; both non-melanoma and melanoma skin cancers were among the top 12 skin diseases reported in the study.
Nearly One-Fourth of DLBCL Cases May Be Attributable to Obesity in Young Adulthood, Says StudyApril 8th 2022
Across all measures, researchers found that body mass index in young adults had the strongest association with the risk of non-Hodgkin lymphoma (NHL), estimating that 23.3% of diffuse large B-cell lymphoma (DLBCL) cases and 11% of NHLs overall can be attributed to obesity.
Researchers Highlight Special Considerations for Managing HS in Certain PopulationsApril 2nd 2022
As potential new treatment options emerge for hidradenitis suppurativa (HS), an inflammatory condition, researchers emphasized the importance of clinicians being prepared to manage patients that have additional health factors.
High CD47 Expression on HRS Cells Carries Poor Survival Implications in Classical HLMarch 27th 2022
Retrospective study findings show that CD47 expression on Hodgkin and Reed–Sternberg (HRS) cells varied between patients who had classical Hodgkin lymphoma (HL) and was associated with poor outcomes.